Bio Contact Education Research Teaching Clinical CV
Picture Not Available
Andrew H Miller, M.D.

Curriculum Vitae

Biographical Section

Name: Andrew H Miller
Degree(s): M.D.
Office Address: PO Drawer AF 4th Floor - WMB
1639 Pierce Dr
Atlanta, GA 30322
Telephone: (404) 727-8260 (Office)
(404) 727-8261 (Lab)
Fax:
Email Address: amill02@emory.edu (University)

Current Primary Academic Appointments

Hire Date: 07/1994 - Current Professor Psychiatry Emory University School of Medicine Atlanta, GA
Hire Date: 09/2005 - Current Professor Hematology and Medical Oncology Emory University School of Medicine Atlanta, GA

Current Joint & Secondary Appointments  

01/1994 - Current Head Laboratory of Neuroendocrine-Immune Interactions, Emory University School of Medicine Atlanta, GA
01/1996 - Current Neuroscience Faculty Member Emory University Graduate Division of Biological and Biomedical Sciences Atlanta, GA
01/2000 - Current Professor Emory University School of Medicine Department of Psychiatry and Behavioral Sciences Atlanta, GA
01/1994 - 01/2000 Associate Professor Emory University School of Medicine Department of Psychiatry and Behavioral Sciences Atlanta, GA

Current Clinical Appointments  

Current Administrative Appointments  

Previous Academic Appointments  

Previous Clinical Appointments  

Previous Administrative Appointments  

Licensure & Board Certifications  

Georgia State Medical Board 038873 01/ 01/
DEA AM1876549 01/ 01/
New York State Medical Boards 151159 01/ 01/1994

Specialty Boards  

National Board of Medical Examiners Diplomate 01/1982 01/
American Board of Psychiatry and Neurology Diplomate 01/1987 01/

Education  

1981 M.D., Medicine Medical College of Georgia Augusta, GA, USA

Postgraduate Training  

01/1985 - 01/1987 Research Fellow in Biological Psychiatry and Psychopharmacology Albert Einstein College of Medicine/ Montefiore Medical Center, Bronx, NY
01/1981 - 01/1985 Psychiatric Residency Albert Einstein College of Medicine/ Montefiore Medical Center Department of Psychiatry, Bronx, NY
01/1982 - 01/1983 Chief Resident Albert Einstein College of Medicine/ Montefiore Medical Center Department of Psychiatry, Bronx, NY
01/1981 - 01/1982 Medical Intership Montefiore Medical Center, Bronx, NY

Military/Government Service  

National & International Committee Memberships  

01/1996 - Current National Institute of Mental Health Ad hoc Reviewer
01/1999 - Current National Institute of Aging Ad hoc Reviewer
01/2000 Planning Committee, Chronic Fatigue and Immune Dysfunction Syndrome Association of America, Inc.
01/1999 Initial Review Group, Mind-Body Centers RFA, Risk, Prevention, & Health Behavior, Center for Scientific Review, National Institutes of Health Member
01/1997 - 01/1998 AIDS Biomedical and Clinical Research Subcommittee, National Institute of Drug Abuse Member
01/1992 - 01/1996 Intial Review Group, Mental Health Aspects of AIDS, Nationa Institute of Mental Health Member
01/1994 Special Review Committee, Mental Health Aspects of AIDS, National Institute of Mental Health Chairman

State & Regional Committee Memberships  

Institutional Committee Memberships  

01/1995 - Current Pharmacy and Therapeutics Committee, Grady Memorial Hospital
01/1995 - 01/1999 Appointments and Promotion Committee, Emory University School of Medicine
01/1996 - 01/1997 Steering Committee, Clinical Research Unit, Grady Memorial Hospital

Consultantships  

01/1998 Zeneca Pharmaceuticals International Advisory Board
01/1998 Janssen Pharmaceutical and Research Foundation Regional Advisory Board

Editorships & Editorial Boards  

Manuscript Reviewer  

01/ - Current American Journal of Psychiatry
01/ - Current Neuropsychopharmacology
01/ - Current Journal of Immunology
01/ - Current Journal of Biological Psychiatry
01/ - Current Psychosomatic Medicine
01/ - Current Journal of Clinical Psychiatry
01/ - Current American Journal of Physiology
01/ - Current Brain
01/ - Current Behavior and Immunity
01/ - Current Psychoneuroendocrinology
01/ - Current Journal of Pharmacology and Experimental Therapeutics
01/ - Current Physiological Processes Section
01/ - Current National Science Foundation
01/ - Current Psychosomatic Medicine
01/ - Current Immunopharmacology
01/ - Current Archives of General Psychiatry

Honors & Awards  

Society Memberships  

01/1987 - Current Society for Neuroscience
01/ - Current American Association for the Advancement of Science
01/ - Current Collegium Internationale Neuropsychopharmacologicum
01/ - Current International Society of Psychoneuroendocrinology
01/ - Current Psychoneuroimmunological Research Society
01/ - Current American College of Neuropsychopharmacology
01/ - Current Endocrine Society

Organization of National/International Conferences: Administrative Positions  

Organization of National/International Conferences: Sessions as Chair  

Research Focus  

Laboratory Interests: Work in Dr. Miller's laboratory addresses the role of the immune system in psychiatric disorders, in particular the potential contribution of the immune system to the pathophysiology of psychiatric disease. Of particular interest are Dr. Miller's recent studies demonstrating the impact of cytokines (and antidepressants) on the expression and function of glucocorticoid receptors. Research Projects: Projects in the laboratory include examination of: 1) The effects of viral infection on the neuroendocrine system of mice. The goals of this project are to determine through what pathways the immune system accesses the endocrine system during viral infection and to determine what the consequences are. We have already shown that interleukin (IL)-6 is the pivotal cytokine for activating the hypothalamic-pituitary-adrenal (HPA) axis in murine cytomegalovirus infection (MCMV) and that the related glucocorticoid response to MCMV is necessary to prevent death following viral infection. If glucocorticoids are blocked, death occurs in MCMV through tumor necrosis factor (TNF)-alpha. We are now examining whether IL-6 activates the HPA axis during MCMV infection through activation of corticotropin releasing factor (CRF). We will also examine what cytokines are involved in CRF activation in the brain (if CRF activation occurs) and what behavioral consequences occur as a result of brain CRF activation. We are employing CRFKO mice and IL-6K0 mice for these studies. 2) Effects of Interferon (IFN) alpha on the neuroendocrine system and behavior of humans. The goal of this project is to apply knowledge gained from our mouse viral studies to understand the mechanism behind the behavioral toxicity observed in patients receiving high dose interferon alpha therapy for malignant melanoma or hepatitis C. IFN-alpha is an important early cytokine in viral infection, and patients receiving IFN-alpha exhibit a high rate of depression. They also show marked activation of IL-6 and the HPA axis. We believe that IL-6 is responsible for glucocorticoid induction during IFN-alpha treatment but that TNF (like in the mouse model) is responsible for the behavioral toxicity. We have access to behavioral measures as well as serum and cells from these patients. We are also using antidepressants as preventative therapy but plan to devise more targeted strategies based on future studies. All results gained from this project may be relevant to depressed patients as a whole, especially those with medical disorders associated with increased release of proinflammatory cytokines. 3) Effects of cytokines and antidepressants on glucocorticoid receptor (GR) function. The impact of cytokines on glucocorticoid receptors may play an important role in the mechanism by which cytokines mediate neurotoxicity. We have recently shown that IL-1 can block the translocation of the GR. Since glucocorticoids serve to feedback negatively on proinflammatory cytokines, impaired GR function as mediated by IL-1 might allow cytokines like TNF to come out from under glucocorticoid control. TNF in turn may mediate neurotoxicity as noted above. Depressed patients exhibit glucocorticoid resistance, and we are investigating the molecular mechanisms for this, possibly converging with pathways involved in the IL-1 effect on GR function (i.e., heat shock proteins). Techniques: Dr. Miller's laboratory and animal facilities are fully equipped for immunological, virological, neuroendocrinological a

Patents Issued

Patents Pending

Active Grant Support: Federally Funded  

Principal Investigator
NIMH
IFN-alpha-Induced Depression: Pathophysiology and Treatment
$1,125,000.00
12/01/2000 - 11/30/2004

Principal Investigator
NIMH
Adrenal Steroid-Immune Interactions
$520,413.00
12/01/1998 - 11/30/2003

Principal Investigator
Centers for Disease Control and Prevention
Interferon Alpha as a Model System to Study Chronic Fatigue Syndrome
$500,000.00
08/01/2000 - 08/01/2003

Principal Investigator
NIMH
Adrenal Steroid-Immune Interaction in Viral Infections
$1,296,482.00
07/01/1998 - 06/30/2003

Principal Investigator
SmithKline Beecham Pharmaceuticals
Paroxetine for the Prevention of IFN-alpha-associated Depression in Patients with Chronic Hepatitis C
$339,000.00
09/01/1999 - 06/01/2002

Principal Investigator
Forest Laboratories
Enhancement of Glucocorticoid Receptor Function by Citalopram
$35,000.00
04/01/2001 - 03/21/2002

Principal Investigator
Schering-Plough Pharmaceuticals
Psychiatric Phone Follow-up of Patients Receiving PEG interferon alfa-2b plus Ribavirin for Chronic Hepatitis C
$40,000.00
02/01/2001 - 02/01/2002

Principal Investigator
Janssen Pharmaceutical and Research Foundation
The Relative Efficacy of Risperidone versus Olanzepine in Preventing the Recurrence of Positive Symptoms in Patients Previously Treated Chronically with Conventional Antipsychotics
$164,730.00
12/01/1999 - 12/01/2001

Principal Investigator
Robert W. Woodruff Health Science Center Fund
Steroid-Independent Regulation of the Glucocorticoid Receptor: Relevance to Pathophysiology and Treatment of Major Depression
$30,000.00
08/01/2000 - 08/01/2001

Active Grant Support: Private Foundation Funded  

Active Grant Support: Contracts  

Active Grant Support: Other  

Previous Grant Support: Federally Funded  

Co-Principle Investigator
Schering-Plough Pharmaceuticals
A Randomized Placebo-Controlled Trial of Paroxetine for the Treatment of Interferon-Alpha-Associated Effects
$250,000.00
09/01/1997 - 09/01/2000

Principal Investigator
NARSAD
Steroid Independent Regulation of Glucocorticoid Receptor Function: Implications for the Pathophysiology and Treatment of Affective Disorders
$100,000.00
09/15/1997 - 06/15/2000

Principal Investigator
NIMH
Adrenal Steroid-Immune Interactions in a Viral Infection
$1,042,420.00
07/01/1994 - 06/30/1998

Principal Investigator
Emory Medical Care Foundation
Phenomenology of Substance Abuse in Schizophrenia
$25,000.00
05/01/1996 - 04/30/1997

Principal Investigator
NIMH
Adrenal Steroid Receptors in immune Cells and Tissues
$160,000.00
03/01/1991 - 02/28/1995

Co-Investigator
MacArthur Foundation
Brain, Behavior, and Immunity
$31,250.00
08/01/1991 - 12/31/1994

Principal Investigator
NIMH
Neuroendocrine-Immune Relationship in Depression
$375,000.00
04/01/1989 - 03/31/1994

Principal Investigator
NIMH
Stress and Immunity in Animals- Neuroendocrine Mechanisms
$50,000.00
04/01/1990 - 03/31/1991

Principal Investigator
NIMH
Depressive Disorders and Immunity
$60,000.00
06/01/1987 - 03/01/1988

Principal Investigator
NIMH
Altered Immunity in Major Depressive Disorder
$15,000.00
05/05/1985 - 10/31/1986

Previous Grant Support: Private Foundation Funded  

Previous Grant Support: Contracts  

Previous Grant Support: Other  

Clinical Service Contributions  

Formal Teaching: Medical Student  

01/1996 - Current Lecturer, 1st and 2nd year medical students, EUSM
01/1989 - 01/1994 Brain and Behavior Course, 2nd Year Medical Students, Mount Sinai School of Medicine, Lecturer, Affective Disorders
01/1992 - 01/1994 Brain and Behavior Course, 2nd year medical students, Mount Sinai School of Medicine, Lecturer, Principals of Neural Transmission

Formal Teaching: Graduate Student  

Formal Teaching: Residency/Training Program  

01/1996 - Current Lecturer, Neuroscience Graduate Program, EUSM
01/1997 - Current Coordinator and Lecturer, Integrated Psychopathology and Psychopharmacology Seminar Series for PGY-2, Department of Psychiatry and Behavioral Sciences, EUSM
01/1997 - Current Coordinator and Lecturer, Orientation Lecture Series on the Major Syndromes for PGY-1, Department of Psychiatry and Behavioral Sciences, EUSM
01/1999 - Current Lecturer, Molecular Endocrinology, Endocrinology Training Grant, Department of Psychiatry and Behavioral Sciences, EUSM
01/1994 - 01/1997 Lecturer and Coordinator, Clinical Psychopharmacology, PGY-2 core Psychopharmacology lecture series, Department of Psychiatry and Behavioral Sciences, EUSM
01/1989 - 01/1991 Course Coordinator, Psychopharmacology Lecture Series, Department of Pschiatry, Mount Sinai Medical Center/Elmhurst Hospital

Formal Teaching: Other (Physician's Assistant, Physical Therapist, etc.)  

Supervisory Teaching: Ph.D. Students Directly Supervised  

Firdaus Dhabher, PhD Research Assistant Professory, Ohio State University
Marni Silverman Neuroscience Graduate Program

Supervisory Teaching: Post-doctoral Fellows Directly Supervised  

Carmine Pariante, MD Clinical Training Fellow, Institute of Psychiatry, London, England
Geraldine Scheller-Gilkey, PhD K01 awardee
Atsufumi Iida, MD Clinical Training Fellow, Department of Psychiatry, Saitama Medical School, Saitama, Japan
Jane Gumnick, MD HIV/AIDS Clinical Research Training Program, Department of Psychiatry, EUSM
Akihiko Oshima, MD, PhD Clinical Training Fellow, Department of Neuropsychiatry, Showa University Fujigaoka Hospital, Yokohama, Kanagawa, Japan
Sherry Broadwell, PhD HIV/AIDS Clinical Research Training Program, Department of Psychiatry, EUSM
Lucile Capuron, PhD Clinical Training Fellow, INSERM, Bordeaux, France

Supervisory Teaching: Residency Program  

Weekly Supervisor, Clinical Psychopharmacology, PGY-1 and PGY-3 residents, Department of Psychiatry, Mount Sinai Medical Center/Elmhurst Hospital
Weekly Supervisor, Clinical Psychopharmacology, PGY-1 and PGY-3 residents, Department of Psychiatry, EUSM

Supervisory Teaching: Other  

1994-present- Lecturer, Basic Prinicipals of Psychopharmacology, for nurses, social workers and psychologists, given approximately 1-2 times per year for different groups
1999- "HPA axis and Depression, Clinical Studies", "The Impact of Early Life Stress on the HPA axis in Humans", Teaching Day, annual meeting of the Psychoneuroimmunological Research Society, Galveston, TX
1999- "Psychoimmunology: Relevance to Psychiatry", Advances in Mood Disorders and Schizophrenia: Diagnosis, Biology and Treatment, for psychiatric residents across the country, Palm Beach, FL

Lectureships, Seminar Invitations, Visiting Professorships  

01/2001 Immune Activation & Glucocorticoid Receptor Function: Relevance to Immune-Based Depression Mind-Body Interactions: An Exploration of the Relationship Between Stress Hormones & Immune Function, Rockefeller University, NY
01/2001 Immune-Based Depression: Mechanisms and Treatment Cytokines and Depression, sponsored by the Association pour la Neuro-Psyco-Pharmacologie, Dinard, France
01/2000 Influences of the Body on the Brain: In Search of the Black Bile Brain Awareness Week, Neuroscience Graduate Division, EUSM
01/2000 Influences of the Body on the Brain: In Search of the Black Bile Psychoneuroimmunolog Conference, Center for Brain Sciences and Health, Departments of Biology and Psychology, Georgia State University
01/2000 Interferon-alpha induced depression as a model of immune-based depression in the medically ill Strategies for Identifying Functional Links Between the Immune System, Brain Function, and Behavior, Division of Neuroscience and Basic Behavioral Research, National Institute of Mental Health
01/2000 CRF and the Immune System Preceptorship, Janssen Pharmaceutical and Research Foundation, Titusville, NJ
01/2000 Antidepressant Prophylaxis for Medically Ill Patients at High Risk for Affective Disorders Hot Topics Session, annual meeting American College of Neuropsychopharmacology, San Juan, PR
01/2000 Immune-Based Depression Grand Rounds, Department of Dermatology, EUSM
01/2000 Mechanism and Treatment of Interferon-Induced Anxiety and Depression in Patients with Malignant Melanoma and Hepatitis C Diagnosis and Treatment of Comorbid Medical and Psychiatric Disorders. CME Program sponsored by EUSM
01/1999 Pretreatment with the antidepressant, paroxeine, attenuates the development of sickness behavior during high dose interferon alpha therapy Annual Meeting, International Society of Psychoneuroendocrinology
01/1999 Cytokines and the Pathophysiology of Depresion Invited Lecture Series, Brown University, Division of Biology and Medicine
01/1999 Pretreatment with the antidepressant, paroxeine, prevents cytokine-induced depression during IFN-alpha therapy for malignant melanoma Research Perspectives in Psychoneuroimmunology
01/1999 Cytokines, Sickness Behavior and the Pathophysiology of Depression: Relevance of the Glucocorticoid Receptor Postgraduate Seminar Series, Baylor College of Medicine
01/1998 Cytokines and the Pathophysiology of Depresion Frontiers of Neuroscience Seminar Series, EUSM
01/1998 Steroid Independent Translocation of the Glucocorticoid Receptor: Implications for the Pathophysiology and Treatment of Affective Disorders Society of Biological Psychiatry
01/1998 Effects of Cytokines on Glucocorticoid Receptor Expression and Function: Relevance for Depression Society for Behavioral Endocrinology
01/1998 Steroid Independent Translocation of the Glucocorticoid Receptor: Implications for the Pathophysiology and Treatment of Affective Disorders Vanderbilt University Department of Psychiatry
01/1998 Steroid Independent Translocation of the Glucocorticoid Receptor: Implications for the Pathophysiology and Treatment of Affective Disorders Mental Health Research Institute, University of Michigan School of Medicine
01/1998 Effects of Cytokines on Glucocorticoid Receptor Expression and Function: Relevance for Depression Cytokines, Stress, and Depression
01/1998 The Immune System in Depression Grand Rounds, Vanderbilt University Deparment of Psychiatry
01/1997 Glucocorticoid Receptor Changes During Viral Infection: Evidence For Steroid Independent Reveptor Regulation Research Perspectives in Psychoneuroimmunology
01/1997 The Immune System in Depression Co-sponsored by Industry and Douglas Hospital
01/1997 Steroid-Independent Translocation of the Glucocorticoid Receptor: Implications for the Pathophysiology and Treatment of Affective Disorders Department of Pharmacology, University of South Carolina School of Medicine
01/1996 Effects of viral Infection on Type II Adrenal Steroid Receptors in Immune Tissues: A novel Pathway for Glucocorticoid-Immune Interactions International Society of Psychoneuroendocrinology
01/1996 Glucocorticoid Receptors in Depression, Implications for the Medically Ill International Society of Psychoneuroendocrinology
01/1996 Effects of viral Infection on Type II Adrenal Steroid Receptors in Immune Tissues: A novel Pathway for Glucocorticoid-Immune Interactions Ohio State University Institute for Behavioral Medicine Research
01/1996 HPA-Immune Interactions During Viral Infection American Psychiatric Association
01/1996 Glucocorticoid-immune interactions during viral infection Research Perspectives in Psychoneuroimmunology
01/1995 Nervous System and Immune System Interactions: New Concepts, New Challenges Grand Rounds, Department of Psychiatry and Behavioral Sciences, EUSM
01/1995 Corticosterone Secretion during Viral Infection International Society of Psychoneuroendocrinology
01/1995 Neuroendocrine-Immune Interactions during Viral Infection NIMH Conference on Psychotherapeutic Drugs and Immune Function
01/1994 Adrenal Steroid-Immune Interactions in Viral Infection Medical College of Ohio
01/1994 Effects of adrenal Steroids on Immune Responses During a Viral Infections Neuroendocrineimmunology
01/1993 Stress and the Immune System MacArthur Foundation Health and Behavior Network
01/1993 Selective Effects of Type I and Type II Adrenal Steriod Receptor Agonists on Immune Cell Distribution in the Peripheral Blood Research Perspectives in Psychoneuroimmunology
01/1993 Adrenal Steroid-Immune Interactions University of Alberta, Canada
01/1992 Neuroendocrine-Immune Interactions in Aging and AIDS National Institutes of Mental Health
01/1992 The Immune System and Depression American Psychiatric Association
01/1992 Depression and Immune Parameters National Multiple Sclerosis Society
01/1992 Depression and the Immune System Signe and Ane Gyllenberg's Foundation, Helsinki, Finland
01/1990 Adrenal Steroid Receptors in immune Cells and Tissues MacArthur Foundation Research Program
01/1990 Psychoimmunology Update Rockefellar University
01/1988 The Immunology of Depression college of Physicians and Surgeons, Columbia University
01/1987 Depressive Disorders and Immunity American Psychiatric Association

Invitations to National/International Conferences  

Community Service  

Other Activities  

Bibliography: Research Articles  

Pariante CM, Pearce BD,Pisell TL, Su C,Miller AH. The steroid receptor antagonists, RU40555 and RU486, activate glucocorticoids receptor translocation and are not excreted by the steroid hormones transporter in L929 cells. (2001). Journal of Endocrinology vol. in press, .
Heim C, Newport DJ,Bonsall RW,Miller AH, Nemeroff CB. Altered pituitary-adrenal axis responses to provocative challenge tests in adult survivors of childhood abuse: Increased pituitary-adrenal and autonomic responses to CRH in adult women after sexual and physical abuse in childhood. (2001). Am J Psychiatry vol. 158, 575-581.
Pariante CM,Miller AH,. Glucocorticoid Receptors in Depression: Relevance to Pathophysiology and Treatment. (2001). Biological Psychiatry vol. 49, 391.
Musselman DL, Lawson D, Gumnick JF,Manatunga A, Penna S, Goodkin RS,Nemeroff CB, Miller AH. Paroxetine precents depression induced by high dose interferon-alpha. (2001). New England Journal of Medicine vol. 344, 961-966.
Musselman DL, Miller AH,Porter MR, Lewison BJ,Nemeroff CB. Hypothalamic-pituitary-adrenal axis hyperactivity and IL-6 plasma concentrations in cancer patients with depression. (2001). American Journal of Psychiatry vol. in press, .
Scheller-Gilkey G, Thomas S,Woolwine B,Miller AH. Early life stress and depressive symptoms in patients with comorbid schizophrenia and substance abuse. (2001). Schizophrenia Bulletin vol. in press, .
Pearce BD, Po CL,Valadi NM,Miller AH. Viral infection of developing GABAergic neurons in a model of hippocampal disinhibition. (2000). Neuroreport vol. 11, 2433-2438.
Heim C, Newport, Heit S,Graham YP, Wilcox M,Bonsall RW, Miller AH, Nemeroff CB. Increased pituitary-adrenal and autonomic responses to stress in adult women after sexual and physical abuse in childhood. (2000). JAMA vol. 284, 592-597.
Swofford CD, Scheller-Gilkey G,Miller AH,Woolwine B, Mance R. Double jeopardy schizophrenia and substance abuse. (2000). Am J Drug Alcohol Abuse vol. 26, 343-353.
Hagan MM, Havel PJ, Seeley RJ,Wood SC, Ekhator NN, Baker DG, Hill KK,Wortman MD, Miller AH, Ginerich RL, Geracioti TD. Cerevrospinal fluid and plasma leptin measurements: covariability with dopamine and cortisol in fasting humans. (1999). J Clin Endocrinol Metab vol. 84, 3579-3585.
Ruzek MC,Pearce BD,Miller AH, Biron CA. Endogenous glucocorticoids protect against cytokine-mediated lethality during viral infection. (1999). Journal of Immunology vol. 162, 3527-3533.
Miller AH,Pariante CM,Pearce BD. Effects of cytokines on glucocorticoid receptor expression and function: glucocorticoid resistance and relevance to depression. (1999). Adv Exp Med Biol vol. 461, 107-116.
Pearce BD, Po CL,Pisell TL,Miller AH. Lymphocytic responses and the gradual hippocampal neuron loss following infection with lymphocytic choriomeningitis virus (LCMV). (1999). J Neuroimmunol vol. 101, 137-147.
Pariante CM, Pearce BD,Pisell TL, Sanchez CI,Po S, Su C, Miller AH. The proinflammatory cytokine, interleukin-1 alpha, reduces glucocorticoid receptor translocation and function. (1999). Endocrinology vol. 140, 4359-4366.
Graham YP, Heim C,Goodman SH, Miller AH,Nemeroff CB. The effects of neonatal stress on brain development: implications for psychopathology. (1999). Development and Psychopathology vol. 11, 545-565.
Miller AH, Spencer RL, Pearce BD,Pisell TL, Azrieli Y, Tanapat P,Moday H, Rhee R, McEwen BS. Glucocorticoid receptors are differentially expressed in the cells and tissues of the immune system. (1998). Cellular Immunology vol. 186, 45-54.
Pariante CM,Pearce BD, Pisell TL,Owens MJ, Miller AH. Steroid-Independent translocation of the glucocorticoid receptor by the antidepressant desipramine. (1998). Molecular Pharmacology vol. 52, 571-581.
Pariante CM, Carpiniello B, Orru MG,Sitzia R, Piras A, Giulia Farci AM,Del Giacco GS, Piludu G, Miller AH. Chronic caregiving stress alters peripheral blood immune parameters: The role of age and severity of stress. (1997). Psychotherapy and Psychosomatics vol. 66, 199-207.
Spencer RL,Moday H,Miller AH. Maintenance of basal ACTH levels by corticosterone and RU28362, but not aldosterone: relationship to available type I and type II corticosteroid receptor levels in brain and pituitary. (1997). Stress vol. 2, 54-61.
Ruzek MC,Miller AH, Opal SM,Pearce BD, Biron CA. Characterization of early cytokine responses and an IL-6-dependent pathway of endogenous glucocorticoid induction during murine cytomegalovirus infection. (1997). Journal of Experimental Medicine vol. 185, 1185-1192.
Miller AH, Spencer RL,Tanapat P, Leung JJ,Dhabhar F, McEwen BS, Biron CA. Effects of viral infection on corticosterone secretion and glucocorticoid receptor binding in immune tissues. (1997). Psychoneuroendocrinology vol. 22, 455-474.
Miller AH, Spencer RL,Moday H, McEwen BS,Blanchard RJ, Blanchard DC, Sakai RR. Chronic social stress produces reductions in available splenic type II corticosteroid receptor binding and corticosteroid binding globulin levels. (1996). Psychoneuroendocrinology vol. 21, 95-109.
Dhabhars FS,Miller AH,McEwen BS, Spencer RL. Stress-induced changes in blood leukocyte distribution: role of adrenal steroid hormones. (1996). Journal of Immunology vol. 157(4), 1638-1644.
Dhabhar FS, Miller AH,McEwen BS,Spencer RL, . Effects of stress on immune cell distribution: dynamics and hormonal mechanisms. (1995). Journal of Immunology vol. 154, 5511-5527.
Orange JS, Salazar-Mather TP,Opal SM, Spencer RL,Miller AH, McEwen BS, Biron CA. Mechanism of IL-12-mediated toxicities during experimental viral infections: role of TNF and glucocorticoids. (1995). Journal of Experimental Medicine vol. 181, 901-914.
Dhabhar FS, Miller AH,McEwen BS,Spencer RL, . Differential activation of adrenal steroid receptors in neural and immune tissues of Sprague Dawley, Fisher 344, and Lewis rats. (1995). Journal of Neuroimmunology vol. 56, 77-90.
Pariante CM,Miller AH,. Natural Killer cell activity in major depression: a prospective study of the in vivo effects of desmethylimipramine treatment. (1995). European Journal of Neuropsychopharmacology vol. Suppl, 83-88.
Miller AH, Spencer RL, Hassett J,Kim C, Rhee R, Ciurea D,Dhabhar F, McEwen BS, Stein M. Effects of selective type I and II adrenal steroid receptor agonsits on immune cell distribution. (1994). Endocrinology vol. 135, 1934-1944.
Miller AH, Sastry G, Speranza AJ,Lawlor BA, Mohs RC, Ryan TM,Gabriel SM, Serby M, Schmeidler J, Davis KL. Dissociation between DST nonsuppression and cortisol hypersecretion in patients with Alzheimer's disease. (1994). American Journal of Psychiatry vol. 151, 267-270.
Dhabhar FS, Miller AH,Stein M, McEwen BS,Spencer RL, . Circadian and acute stress-induced changes in distribution of peripheral blood leukocyte subpopulations. (1994). Brain, Behavior & Immunity vol. 8, 66-79.
Miller AH, Spencer RL,Husain A, Rhee R,McEwen BS, Stein M. Differential expression of type I adrenal steroid receptors in immune tissues is associated with tissue specific regulation of type II receptors by aldosterone. (1993). Endocrinology vol. 133, 2133-2140.
Miller AH, Spencer RL,Moday H,Stein M, McEwen BS. Diurnal differences in basal and acute stress levels of type I and type II adrenal steroid receptor activation in neural and immune tissues. (1993). Endocrinology vol. 133, 1941-1950.
Miller AH, Spencer RL,Pulera M, Kang S,McEwan BS, Stein M. Adrenal steroid receptor activation in rat brain and pituitary following dexamethasone: implications for the dexamethasone suppression test. (1992). Biological Psychiatry vol. 32, 850-869.
Miller AH, Spencer RL,Trestman RL, Kim C,Stein M, McEwen BS. Adrenal steroid receptor activation in vivo and immune function. (1991). American Journal of Physiology vol. 261(1), E126-131.
Spencer RL,Miller AH,Stein M, McEwen BS. Corticosterone regulation of type I and type II adrenal steroid receptors in brain, pituitary, and immune tissue. (1991). Brain Res vol. 549(2), 236-246.
Halper JP, Miller AH,Trestman RL, Santucci AC,Lackner C, Stein M. Biochemical mechanisms of stress-induced impairment of rat T cell mitogenesis. (1991). Journal of Neuroimmunology vol. 32(3), 241-247.
Miller AH,Asnis GM, Lachner C,Halbreich U, Norin AJ. Depression, natural killer cell activity, and cortisol secretion. (1991). Biological Psychiatry vol. 29, 878-886.
Miller AH,Spencer RL,Stein M, McEwen BS. Adrenal steroid receptor binding in spleen and thymus after stress or dexamethasone. (1990). American Journal of Physiology vol. 259, .
Asnis GM, Harkavy Friedman JM, Miller AH,Iqbal I, Lo ES, Cooper TB,Halbreich U, Lemus CA, van Praag HM, Rubinson E. Plasma dexamethasone and cortisol levels in depressed outpatients. (1989). Journal of Affective Disorders vol. 16, 5-10.
Foley FW,Miller AH, LaRocca NG,Traugot U, Scheinberg L. Psychoimmunological dysregulation in multiple sclerosis. (1988). Psychosomatics vol. 29, 398-403.
Asnis GM, Eisenberg J,van Praag HM, Lemus CZ,Friedman JM, Miller AH. The neuroendocrine response to fenfluramine in depressives and normal controls. (1988). Biological Psychiatry vol. 24, 117-120.
Miller AH,Asnis GM,Lackner C, Norin AJ. The in vitro effect of cortisol on natural killer cell activity in patients with major depressive disorder. (1987). Psychopharmacology Bulletin vol. 23, 502-504.
Miller AH,Silberstein C,Asnis GM. Epstein Barr virus infection and depression. (1986). Journal of Clinical Psychiatry vol. 47, 529-530.
Miller AH,Asnis GM,van Praag HM, Norin AJ. The influence of desmethylimipramine on natural killer cell activity. (1986). Psychiatry Research vol. 19, 9-15.

Bibliography: Manuscripts  

Bibliography: Article Reviews  

Bibliography: Book Reviews  

Bibliography: Symposium Contributions  

Bibliography: Books Edited and Written  

,,. Miller AH,Spiegel D, (ed). (1989). Depressive Disorders and Immunity. Washington, DC:American Psychiatric Press.

Bibliography: Films and Training Videos  

Bibliography: Training Manuals  

Bibliography: Software and Computer Programs  

Bibliography: Published Abstracts  

Bibliography: Other Publications  

Miller AH, Asnis GM, van Praag HM, Norin AJ. (1985). Reversible inhibition of natural killer activity by the tricyclic antidepressant desmethylimipramine. Journal of Leukocyte Biology , Vol. 38 , pp. 184.

Miller AH, Asnis GM, Lackner C, Norin AJ. (1988). Depression, cortisol secretion and leukocyte traffic. Montreal, Canada: New Research Abstract presented at the annual meeting of the American Psychiatric Association .

Halper JP, Miller AH, Lackner C, Trestman B, Berkenbosh F, Santucci A, Haroutunian V, Stein M. (1989). Effect of brief stressors on lymphocyte function in rats: Mechanistic implications. Phoenix, AZ: Neuroscience Abstract, presented at the annual meeting of the Society of Neuroscience .

Miller AH, Spencer RL, Stein M, McEwen BS. (1989). Clucocorticoid binding in immune tussues is less affected by stress levels of corticosterone compared to brain. Phoenix, AZ: Neuroscience Abstract, presented at the annual meeting of the Society of Neuroscience .

Miller AH, Spencer RL, Stein M, McEwen BS. (1990). Chronic corticosteroid exposure downregulates adrenal steroid receptors in hippocampus and spleen byt not pituitary. Biological Psychaitry , Vol. 27(9A) , pp. 142A.

Miller AH, Spencer RL, Kim C, Trestman R, McEwan BS, Stein M. (1990). Adrenal steroid receptor activation in vivo highly correlates with immune function as measured in vitro. St. Louis, MO: Neuroscience Abstract, presented at the annual meeting of the Society of Neuroscience .

Spencer RL, Miller AH, McEwen BS. (1990). Cortisterone regulation of adrenal steroid receptor level in brain and immune tissue. St. Louis, MO: Neuroscience Abstract, presented at the annual meeting of the Society of Neuroscience .

Miller AH, Spencer RL, Pulera M, Kang S, McEwan BS, Stein M. (1991). Adrenal steroid receptor activation in brain and pituitary by dexamethasone and corticosterone. New Orleans, LA: Neuroscience Abstract, presented at the annual meeting of the Society of Neuroscience .

Spencer RL, Miller AH, Kang SS, Stein M, McEwen BS. (1991). Diurnal comparison of adrenal steroid receptor activation in brain, pituitary and immune tissue. New Orleans, LA: Neuroscience Abstract, presented at the annual meeting of the Society of Neuroscience .

Sastry G, Miller AH, Serby M, Lawlor B, Ryan T, Gabriel SM, Mohs R, Davis K. (1992). HPA axis, behavior and Alzheimer's Disease. Biological Psychaitry , Vol. 31 , pp. 154A.

Kim C, Miller AH, Spencer RL, Hasset J, McEwan BS, Stein M. (1992). Effects of type I and II adrenal steroid receptor agonists on peripheral blood immune cells in the rat. Biological Psychaitry , Vol. 31 , pp. 220A.

Miller AH, Spencer RL, Hasset J, Kim CH, Husain A, McEwen BS, Stein M. (1992). Type I and II adrenal steroid receptor agonists have selective effects on peripheral blood immune cells in the rat. Anaheim, CA: Neuroscience Abstract, presented at the annual meeting of the Society of Neuroscience .

Sakai RR, Weiss SM, Blanchard DC, Blanchard RJ, Spencer RL, Miller AH, McEwen BS. (1992). Chronic social stress in rats: Effects on glucocorticoid secretion and corticosteroid binding globulin. Anaheim, CA: Neuroscience Abstract, presented at the annual meeting of the Society of Neuroscience .

Spencer RL, Miller AH, Moday H, Stein M, McEwen BS. (1992). The role of type I and type II adrenal steroid receptors in maintenance of basal ACTH levels. Anaheim, CA: Neuroscience Abstract, presented at the annual meeting of the Society of Neuroscience .

Spencer RL, Miller AH, Dhabher FS, Moday H, Stein M, McEwen BS. (1993). Expression and activation of adrenal steroid receptors in immune tissues. Boulder, CO: Research Perspectives in Psychoneuroimmunology IV .

Dhabhar FS, Miller AH, Spencer RL, Moday H, Hasset J, Stein M, McEwen BS. (1993). Diurnal and acute stress effects on immune cells subpopulations in the rat. Boulder, CO: Research Perspectives in Psychoneuroimmunology IV .

Dhabhar FS, Miller AH, Moday H, McEwen BS, Rhee R, Stein M, Spencer RL. (1993). Stress-induced changes in the distribution of leukocyte subpopulations in peripheral blood. Washington, DC: Presented at the annual meeting of the Society of Neuroscience .

Spencer RL, Miller AH, McEwen BS. (1993). Nuclear versus cytoplasmic glucocorticoid receptor immunoreactivity in hippocampus of adrenalextomized and intact rats: different profiles with two different antibodies. Washington, DC: Presented at the annual meeting of the Society of Neuroscience .

Miller AH, Spencer RL, Moday H, McEwen BS, Rhee R, Vaananen H, Stein M. (1993). Immune cell subtypes exhibit significant heterogeneity in the expression of type II adrenal steroid receptors. Washington, DC: Presented at the annual meeting of the Society of Neuroscience .

McEwen BS, Dhabhar F, Miller AH, Spencer RL, Stein M. (1993). Heterogeneity and compartmentalization of adrenal steroid modulation of immune function. Denver, CO: Presented at the American Association of Immunologists .

Biron CA, Miller AH, Spencer RL, Leung JJ, Theroux DM, Orange JS, Salazar-Mather T, Su C, McEwen BS. (1994). Adrenal steroid-mediated regulation of immune responses to LCMV infection. FASEB J , Vol. 8 , pp. A976.

Miller AH, Biron CA, Spencer RL, Tanapat P, Dhabhar F, Leung J, McEwen BS. (1994). Adrenal steroid-immune interactions in a viral infection. Bethesda, MD: Presented at the First World Congress on Stress .

Orange JS, Wolf SF, Miller AH, Spencer RL, McEwen BS, Opal SM, Biron CA. (1994). Mechanism for IL-12 mediated effects on resistance to viral infection: low dose enhancement of protective immune responses as compared to high dose immunotoxicity associated with TNF and adrenal steroid induction. Presented at IL-12 meeting .

Miller AH, Biron CA, Spencer RL, Tanapat P, Leung J, Dhabhar F, McEwen BS. (1994). Effects of viral infection on adrenal steroid secretion and adrenal steroid receptor expression. Miami, FL: Presented at the 24th annual meeting of the Society of Neuroscience .

Spencer RL, Miller AH, Moday H, McEwen BS. (1994). Western blot analysis of cytosolic and nuclear type II corticosteroid levels in rat brain. Miami, FL: Presented at the 24th annual meeting of the Society of Neuroscience .

McEwen BS, Dhabhar F, Miller AH, Spencer RL, . (1994). Adrenal steroids are multifactorial modulators of immune function: studies of receptor distribution and immune cell trafficking. Presented at the Lovelace Institute .

Dhabhar, FS, Miller AH, McEwen BS, Spencer RL. (1994). Stress-induced changes in leukocyte distribution- hormone dependency. Society for Neuroscience Abst. , Vol. 20(1-2) , pp. 949.

Miller AH, Pearce BD, Pisell TL, Orange JS, Su HS, Leung JJ, Biron CA. (1995). The impact of different viral infections on corticosterone secretion in mice. San Diego, CA: Presented at the 25th annual meeting of the Society of Neuroscience .

Scheller-Gilkey G, Swofford C, Mance R, farill M, Woolwine B, Miller A. (1995). Double jeopardy: schizophrenia and substance abuse. Boston, MA: Presented at the annual meeting of the Institute on Psychiatric Services .

Scheller-Gilkey G, Mance R, Woolwine B, Swofford C, Chadwick N, Miller AH. (1995). Beyond schizophrenia subtypes: implications for service delivery. Boston, MA: Presented at the annual meeting of the Institute on Psychiatric Services .

Mance R, Scheller-Gilkey G, Swofford C, Farill M, Chadwick N, Woolwine B, Miller A. (1995). Who, when and how does clozapine help? A community mental health experience. Boston, MA: Presented at the annual meeting of the Institute on Psychiatric Services .

Pearce BD, Steffensen SC, Paoletti AD, Miller AH, Henrikson SJ, Buchmeier MJ. (1995). Quantification and specificity of hippocampal neuronal loss following neonatal infection with LCMV. San Diego, CA: Presented at the 25th annual meeting of the Society of Neuroscience .

Pariante CM, Pisell TL, Pearce BD, McEwen BS, Miller AH. (1995). RU40555 inhibits dexamethasone-induced translocation of the type II glucocorticoid receptor from the cytoplasm to the nucleus. San Diego, CA: Presented at the 25th annual meeting of the Society of Neuroscience .

Pariante CM, Pearce BD, Pisell TL, Miller AH. (1996). In vitro effects of cytokines on glucocorticoid receptor function. Santa Monica, CA: Research Perspectives in Psychoneuroimmunology IV .

Pariante CM, Pearce BD, Pisell TL, Miller AH. (1996). Desmethylimipramine induced glucocorticoid receptor translocation in vitro. New York, NY: Presented at the annual meeting of the American Psychiatric Association .

Ruzek MC, Miller AH, Opal SM, Pearce BD, Biron CA. (1996). Characterization of IL-6 dependent glucocorticoid induction during viral infection. Bethesda, MD: International Conference of the International Society for Neuroimmunomodulation .

Pariante CM, Pearce BD, Pisell TL, Miller AH. (1996). Interleukin-1 alpha inhibits neucleocytoplasmic traffic of the glucocorticoid receptor. Bethesda, MD: International Conference of the International Society for Neuroimmunomodulation .

Pariante CM, Pearce BD, Pisell TL, Miller AH. (1996). Steroid-independent regulation of glucocorticoid receptor function. Washington, DC: Neuroscience Abstract, presented at the annual meeting of the Society of Neuroscience .

Miller AH, Pearce BD, Pisell TL, Pariante CM, Biron CA. (1996). Adrenal independent changes in glucocorticoid receptor binding during viral infection. Washington, DC: Neuroscience Abstract, presented at the annual meeting of the Society of Neuroscience .

Pariante CM, Pearce BD, Pisell TL, Miller AH. (1996). Antidepressant and proinflammatory cytokines as possible steroid-independent modulators of glucocorticoid receptor function. San Juan, PR: Scientific Abstract. presented at the 35th annual meeting of the American College of Neuropsychopharmacology .

Pariante CM, Pearce BD, Pisell TL, Miller AH. (1996). Mechanism of action of the glucocorticoid receptor antagonist, RU40555. Washington, DC: Neuroscience Abstract, presented at the annual meeting of the Society of Neuroscience .

Pearce BD, Steffensen SC, Paoletti AD, Miller AH, Henrikson SJ, Buchmeier MJ. (1996). Virus-induced pathology in the developing hippocampus may involve disruption of inhibitory circuits. Presented at the Symposium on the Neurovirology and Immunology of Schizophrenia and Bipolar Disorder .

Pearce BD, Po CL, Pisell TL, Miller AH. (1996). The immune response in the disruption of hippocampal GABA circuits following neonatal infection with lymphocytic choriomeningitis virus. Bethesda, MD: Presented at the 2nd Symposium on the Neurovirology and Immunology of Schizophrenia and Bipolar Disorder .

Ruzek MC, Miller AH, Opal SM, Pearce BD, Biron CA. (1997). Endogenous Cytokine and Glucocorticoid Interactions during murine cytomegalovirus infection. Boulder, CO: Psychoneuroimmunology ResearchSoceity Meeting .

Ruzek MC, Miller AH, Pearce BD, Spencer RL, Biron CA. (1997). Evidence for endogenous glucocorticoids protection against MCMV-induced lethality. New Orleans, LA: Society for Neuroscience Abst. .

Ruzek MC, Miller AH, Opal SM, Pearce BD, Biron CA. (1997). Reciprocal regulation of endogenous glucocorticoids and cytokine production during murine cytomegalovirs infection. Copper Mountain, CO: Keystone Symposia .

Pariante CM, Pearce BD, Pisell TL, Owens MJ, Miller AH. (1997). Steroid-Independent translocation of the glucocorticoid receptor by the antidepressant desipramine. New Orleans, LA: Society of Neuroscience .

Musselman DL, Pissel TL, Lewison B, Pearce BD, Knight BT, Ninan PT, Nemeroff CB, Miller AH. (1997). Interleukin-6 plasma concentration in cancer patients with depression. New Orleans, LA: Society of Neuroscience .

Heim C, Pisell TL, Pearce BD, Miller AH. (1997). Discrimination of activation versus down-regulation of the glucocorticoid receptor using a cytosolic binding assay combined witha whole cell Western blot. New Orleans, LA: Society of Neuroscience .

Pariante CM, Pearce BD, Pisell TL, Sanchez CI, Miller AH. (1997). Steroid independent modulation of glucocorticoid receptor translocation and glucocorticoid-mediated gene transcription. Hawaii: Presented at the 36th annual meeting of the American College of Neuropsychopharmacology .

Pariante CM, Pearce BD, Heim C, Sanchez C, Miller AH. (1998). The tricyclic antidepressant, desipramine, induces nuclear translocation of the glucocorticoid receptor in primary human fibroblasts. Tier, Germany: International Society of Psychoneuroendocrinology .

Pariante CM, Pearce BD, Pisell TL, Sanchez CI, Po S, Su C, Miller AH. (1998). The proinflammatory cytokine, interleukin-1 alpha, reduces glucocorticoid receptor translocation and function. Los Angeles, CA: Society of Neuroscience .

Pariante CM, Pearce BD, Sanchez CI, Miller AH. (1998). The antidepressant, desipramine, activates glucocorticoid receptor translocation and function in primary human fibroblasts. Los Angeles, CA: Society of Neuroscience .

Heim C, Graham YP, Heit S, Bonsall R, Miller AH, Nemeroff CB. (1998). Increases reactivity of the hypothalamic-pituitary-adrenal (HPA) axis to psychosocial stress in adult survivors of childhood abuse. Los Angeles, CA: Society of Neuroscience .

Ruzek MC, Miller AH, Pearce BD, Biron CA. (1998). Different immune cell requirements for glucocorticoid induction in response to particular viral infections. Los Angeles, CA: Society of Neuroscience .

Musselman DL, Lawson D, Penna S, Pearce BD, Su C, Miller AH, Nemeroff CB. (1999). Paroxetine pretreatment reduces interferon-alpha-induced depression. Washington, DC: Society of Biological Psychiatry .

Miller AH, Musselman D, Penna S, Su C, Pearce BD, Nemeroff C. (1999). Pretreatment with the antidepressant, paroxetine, prevents cytokine-induced depression during IFN-alpha therapy for malignant melanoma. Neuroimmunomodulation , Vol. 6 , pp. 237.

Pariante CM, Pearce BD, Sanchez CI, Owens MJ, Sulser F, Miller AH. (1999). Steroid-independent translocation of the glucocorticoid receptor by the antidepressants: a new mechanism of action for this class of drugs?. International Journal of Neurpsychopharmacology , Vol. 2 , pp. S7.

Miller AH, Musselman D, Pearce BD, Penna S, Nemeroff CB. (1999). Pretreatment with the antidepressant, paroxetine, blocks the development of behavioral altercations in humans during high dose interferon alpha therapy. Miami, FL: Society of Neuroscience .

Heim C, Newport, Heit S, Graham YP, Bonsall R, Miller AH, Nemeroff CB. (1999). Pituitary-adrenal responses to CRF stimulation in adult survivors of childhood abuse with and without depression. Miami, FL: Society of Neuroscience .

Pearce BD, Ruzek MC, Karalis K, Venihaki M, Silverman MN, Biron CA, Miller AH. (1999). CRH-independent activation of corticosterone release during viral infection. Miami, FL: Society of Neuroscience .

Nemeroff CB, Heim C, Newport J, Miller AH. (1999). Persistent effects of untoward life events in humans: implications for pathophysiology and treatment. Acapulco, Mexico: Presented at the 38th annual meeting of the American College of Neuropsychopharmacology .

Scheller-Gilkey G, Woolwine B, Robinson I, Gay O, Miller AH. (2000). Atypical medications in schizophrenia patients witha history of substance abuse. .

Lawson DH, Musselman DL, Penna S, Greiner K, Pearce BD, Miller AH, Nemeroff CB. (2000). Pretreatment with paroxetine significantly decreases interferon alpha-2b stimulated increases in plasma ACTH and IL-6 levels. American Association of Cancer Research .

Gumnick JF, Pearce BD, Pariante CM, Su Y, Goodkin RS, Reemsnyder AJ, Lawson DH, Musselman DL, Miller AH. (2000). Paroxetine pretreatment significantly decreases the initial IL-6 response to interferon-alpha administration in patient with malignant melanoma. Brain, Behavior, and Immunity , Vol. 14 , pp. 99.

Silverman MN, Pearce BD, Ruzek MC, Karalis K, Venihaki M, Biron CA, Miller AH. (2000). Virus-induced corticosterone release through CRH-independent pathways. Brain, Behavior, and Immunity , Vol. 14 , pp. 130.

Silverman MN, Pearce BD, Biron CA, Miller AH. (2000). Virus-induced corticosterone responses in hypophysectomized mice. New Orleans, LA: Society of Neuroscience .

Pariante CM, Dayanandan R, Heyden A, Ackerely S, Grierson G, Nebbia S, Lovestone S, Makoff A, Danielsen M, Pearce BD, Miller AH, Kerwin RW. (2000). A new green fluorescent protein-glucocorticoid receptor (GR) chimera to study steroid-independent regulation of the GR in cell lines and in rat cortical and hippocampal neurons. New Orleans, LA: Society of Neuroscience .

Valadi NM, Miller AH, Po C, Pearce BD. (2000). Viral infection of GABA-ergic neurons in hippocampal disinhibition. New Orleans, LA: Society of Neuroscience .

Pariante CM, Oshima A, Makoff AH, Vogt G, Kerwin RW, Pearce BD, Miller AH. (2000). Enhanced glucocorticoids receptor-mediated gene transcription in vitro by chemically unrelated antidepressants. San Juan, PR: American College of Neuropsychopharmacology .

© 2014 Emory University
Last Update: 04/24/2014